LOCATIONS: NEW YORK CITY | LONG ISLAND
BOOK YOUR CONSULTATION NOW: 917-261-7370
Bipolar depression and major depression can produce many of the same depressive symptoms, but they are not the same disorder. The defining difference is a history of mania or hypomania. Major depressive disorder does not include manic or hypomanic episodes; bipolar I disorder includes mania, while bipolar II disorder includes hypomania and major depressive episodes. Because a person may seek treatment while depressed—and may not recognize a previous period of hypomania—the distinction sometimes requires a careful review of mood history, sleep, energy, behavior, family observations, and previous treatment responses. National Institute of Mental Health (NIMH)
This is an educational article about Bipolar Depression vs. Major Depression and is not a diagnostic tool. A psychiatrist or other qualified clinician should evaluate persistent or severe mood symptoms.
A depressive episode can involve persistent sadness or hopelessness, loss of interest, fatigue, changes in sleep or appetite, difficulty concentrating, feelings of worthlessness, and thoughts of death or suicide. These symptoms can occur in major depressive disorder and during the depressive phase of bipolar disorder. NIMH’s depression overview describes many of these same symptoms.
That overlap is why the depressive episode itself may not reveal whether someone has unipolar major depression or bipolar disorder. Clinical reviews emphasize that the key diagnostic question is whether mania or hypomania has occurred at another point in the person’s life. A review indexed in PubMed notes that the presentation of a major depressive episode in bipolar disorder may not differ substantially from unipolar depression.
| Feature | Major Depressive Disorder | Bipolar Depression |
|---|---|---|
| Depressive episodes | Yes | Yes |
| History of mania | No | Bipolar I: yes |
| History of hypomania | No | Bipolar II: yes |
| Elevated/irritable periods with increased energy | Not part of MDD diagnosis | May occur as mania or hypomania |
| Decreased need for sleep during an “up” episode | Not a defining MDD feature | Can be an important clue |
| Treatment approach | Often includes psychotherapy and/or antidepressant treatment | Typically requires a bipolar-specific treatment strategy; medication choices differ |
| Need to review lifetime mood history | Important | Especially important because prior hypomania may be overlooked |
The clearest distinction is the person’s history outside the depressive episode. NIMH describes bipolar disorder as involving marked shifts in mood, energy, activity, and concentration, including manic episodes and, for some people, hypomanic episodes.
During mania, a person may experience an unusually elevated, energized, or highly irritable mood along with major changes in activity and behavior. Possible signs include racing thoughts, unusually rapid speech, increased activity, inflated confidence or grandiosity, impulsive or risky behavior, and needing much less sleep without feeling tired.
Hypomania involves a noticeable change in mood, energy, and functioning that is less severe than full mania. It may even feel productive or positive to the person experiencing it. That can make it easy to overlook when someone later seeks help during a depressive episode. Family members or partners may notice the change more readily than the individual.
A recent review of bipolar II disorder emphasizes that the diagnostic distinction from major depressive disorder relies on a history of hypomania and that collateral information from people close to the patient can be useful. Read the review in PubMed Central.
No single symptom proves that depression is bipolar. However, when evaluating someone who presents with depression, clinicians may explore:
These are clues for a professional evaluation—not a checklist for self-diagnosis. Differential diagnosis can be complex because other psychiatric, medical, medication-related, and substance-related conditions can also affect mood. CANMAT/ISBD bipolar disorder guidelines discuss several conditions clinicians consider in the differential diagnosis.
People with bipolar disorder often seek care because they are depressed, not because they recognize a past “high” as clinically important. Hypomania in particular may not feel like an illness. Someone may remember being unusually energetic, sleeping less, talking more, or being exceptionally productive without identifying the period as a mood episode.
This creates a diagnostic challenge. Research reviews have repeatedly described substantial symptom overlap between bipolar depression and major depressive disorder, particularly when a person is currently depressed. A 2025 review describes the difficulty of distinguishing bipolar II disorder from major depressive disorder and the importance of a detailed clinical evaluation.
The distinction is not merely a label. Major depressive disorder and bipolar disorder have different treatment frameworks, and medication selection can differ substantially. A clinician treating bipolar depression considers not only relief of depressive symptoms but also the patient’s history of mania or hypomania, the risk of mood destabilization, current medications, other health conditions, and the overall course of the illness.
Evidence-based bipolar guidelines caution that antidepressant treatment has a different role in bipolar disorder than it does in unipolar major depression. CANMAT/ISBD guidelines provide detailed recommendations for acute and maintenance treatment of bipolar disorder.
For this reason, someone with persistent or treatment-resistant depression should tell the evaluating clinician about any previous periods of unusually high energy, reduced need for sleep, impulsivity, agitation, or mood elevation—even if those periods occurred years earlier.
Treatment may include psychotherapy, medication, or a combination of approaches, depending on symptom severity, prior treatment history, medical factors, and patient preferences. NIMH provides an overview of depression diagnosis and treatment.
Treatment is individualized around the bipolar diagnosis. Depending on the clinical situation, a psychiatrist may consider mood-stabilizing medications, certain atypical antipsychotic medications, psychotherapy, and other interventions. Long-term care also considers prevention of both depressive and manic or hypomanic episodes.
Because treatment decisions can be affected by the type of bipolar disorder, current mood state, previous episodes, medication history, and other medical or psychiatric conditions, treatment should be directed by a clinician experienced in mood disorders.
Some people continue to experience significant bipolar depressive symptoms despite appropriate conventional treatment. This is an area in which clinicians and researchers have investigated additional treatment strategies, including ketamine.
At NY Ketamine Infusions, the relevant question is not simply whether ketamine can reduce depressive symptoms; it is whether a patient has been appropriately evaluated and whether treatment is clinically appropriate in the context of bipolar disorder. Learn more about NY Ketamine Infusions’ bipolar depression treatment approach.
The evidence for IV ketamine in bipolar depression is promising but remains more limited than the evidence base for unipolar treatment-resistant depression. An updated systematic review found preliminary evidence of antidepressant benefit in bipolar depression while also emphasizing the need for larger and longer-term studies. In the studies reviewed, IV ketamine was generally administered as an adjunct to a mood-stabilizing agent, and a small number of participants developed hypomanic or manic symptoms.
A separate systematic review and meta-analysis likewise reported antidepressant effects in studied bipolar-depression populations but concluded that larger studies are needed to strengthen the evidence.
Ketamine is therefore not a substitute for establishing the correct diagnosis or for comprehensive bipolar disorder management.
A useful evaluation looks beyond how you feel today. Be prepared to discuss your lifetime mood history. Questions may include:
Keeping a simple timeline of mood episodes, sleep changes, medication trials, and major behavioral changes can help make the clinical conversation more specific.
It can feel very similar. Both can involve low mood, loss of interest, fatigue, sleep or appetite changes, concentration problems, hopelessness, and suicidal thoughts. The diagnosis depends on the broader lifetime mood history, especially whether mania or hypomania has occurred.
A past manic or hypomanic episode is the defining distinction. Periods of markedly increased energy, reduced need for sleep, racing thoughts, unusually rapid speech, mood elevation or intense irritability, and uncharacteristic risk-taking are important to discuss with a clinician.
Yes. Hypomania may feel productive or positive and may not cause the same level of disruption as mania. People close to the individual sometimes recognize the change in mood, sleep, energy, or behavior more readily.
Bipolar depression refers to the depressive phase or depressive episodes that occur within bipolar disorder. Bipolar disorder also involves a history of mania in bipolar I or hypomania in bipolar II.
Treatment plans differ because bipolar disorder requires attention to both depressive symptoms and the possibility of mania or hypomania. Medication strategies used for major depressive disorder cannot simply be assumed to be appropriate for bipolar depression.
In some circumstances clinicians may use antidepressants as part of a bipolar treatment plan, but their role is different from treatment of unipolar major depression. Decisions should be individualized and supervised by a clinician familiar with bipolar disorder.
Ketamine has been studied for bipolar depression, and systematic reviews report promising but still limited evidence. Published studies commonly used IV ketamine alongside a mood-stabilizing treatment. Careful screening and medical supervision are important because bipolar disorder requires a broader treatment strategy.
A psychiatric or medical evaluation can help clarify the diagnosis and treatment history. NY Ketamine Infusions evaluates adults in New York City and Long Island to determine whether ketamine-based treatment may be appropriate for qualifying patients.
If depression is persistent, recurrent, worsening, or not responding to treatment, a comprehensive evaluation can help determine whether the diagnosis and treatment strategy should be reconsidered. If you have experienced possible mania or hypomania, mention it explicitly rather than focusing only on current depressive symptoms.
If you or someone you know is in crisis or having thoughts of suicide, call or text 988 to reach the Suicide & Crisis Lifeline. In a life-threatening emergency, call 911.
NY Ketamine Infusions provides medically supervised treatment for eligible adults with difficult-to-treat mood disorders in New York City and Long Island. A consultation is designed to review diagnosis, symptoms, treatment history, medications, and relevant medical factors before determining whether ketamine treatment should be considered. Schedule a consultation or read more about ketamine treatment for bipolar depression
Going from depression and suicidality to enjoying his life and time with his family again is just the tip of the iceberg for Arthur’s new life after ketamine infusion.
Arthur knows hope isn’t always easy to find, but ketamine helped him get there.
NY Ketamine Infusions provides advanced Ketamine therapy and insurance-covered SPRAVATO® treatment options for patients near Lower Manhattan and surrounding New York City communities. Our team helps patients explore treatment options for anxiety, depression, PTSD, OCD, Bipolar Disorder, Alcohol Dependence, and treatment-resistant depression in a supportive clinical setting.
160 Broadway, 16th Floor, New York, NY 10038
Phone: 917-261-7370
Treatment Hours:
7 days a week: 9AM to 7PM
150 Broadhollow Rd, Suite 103, Melville, NY 11747
Phone: 631-629-4626
Treatment Hours:
Monday, Wednesday, Friday from 9AM to 5PM
Our protocol requires a brief intake conversation with one of our physicians to determine if ketamine is likely to help you. Please fill out the form below and you will be contacted by our Patient Care Team within 24 hours. After submitting, you’ll get the opportunity to provide more personal information via an optional questionnaire.
